Ownership history in Bellevue Group AG · 21 quarters on record
This page tracks every 13F SEC filing in which Bellevue Group AG reported a position in REVOLUTION MEDICINES INC (RVMD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 5,005,719 | -568,119 | -10.2% | 7.56% | $398.7M | $79.65 |
| 2025 Q3 | ADDED | 5,573,838 | +994,538 | +21.7% | 5.41% | $260.3M | $46.70 |
| 2025 Q2 | ADDED | 4,579,300 | +205,000 | +4.7% | 3.71% | $168.5M | $36.79 |
| 2025 Q1 | REDUCED | 4,374,300 | -12,600 | -0.3% | 3.47% | $154.7M | $35.36 |
As of 2025 Q4 — sorted by position size